- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT03949829
El estudio de CoPenhague sobre la PREeclampsia y la enfermedad cardIOvascUlar (CPH-PRECIOUS)
Enfermedad cardiovascular después de la preeclampsia
Women with a history of preeclampsia (PE) have increased risk of hypertension and cardiovascular disease (CVD) later in life. Thus, PE is acknowledged as an independent risk factor for CVD, which is the number one cause of death in women in the western part of the world.
Objective:
The purpose of this study is to investigate 1) the prevalence of CVD after PE, 2) which women have the highest risk of developing CVD, 3) when early stages of CVD can be detected in women with previous PE and 4) how CVD progress over time.
Methods:
1000 women with previous PE between the age of 35-55 years will be invited to participate in a follow-up study consisting of anthropometric measurements, blood pressure measurement, urine- and blood samples, cardiac CT-scan and questionnaires. Coronary atherosclerosis will be evaluated using CT imaging.The women will be compared with women with a formerly uncomplicated pregnancy,
Summary:
The study will provide new important information to guide future clinical follow-up, and potentially prevent disease and early death in a large group of women with a history of PE.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Women with a history of preeclampsia (PE) have increased risk of hypertension and cardiovascular disease (CVD) later in life. Thus, PE is acknowledged as an independent risk factor for CVD, which is the number one cause of death in women in the western part of the world. Despite this, solid and uniform guidelines regarding follow-up after a pregnancy complicated by PE are lacking. Little is known about the time-course of the development of CVD and how early stages can be identified in women with previous PE. The link between PE and CVD is well established. However, no large clinical study using cardiac CT-scans exists. Moreover, the study will focus on the time-perspective of the development of CVD in relation to index pregnancy, and this knowledge may prove to be essential to establish solid clinical guidelines addressing timely prevention and treatment.
The purpose of this study is to investigate
- The prevalence of CVD after PE,
- Which women have the highest risk of developing CVD
- When early stages of CVD can be detected in women with previous PE
- How CVD progress over time.
Thus, we hope to identify a window of opportunity where screening and preventive measures may be relevant and potentially beneficial to these women.
A total of 1000 women with previous PE (aged 35-55 years) will be invited to participate in a clinical follow-up study consisting of anthropometric measurements, blood pressure measurement, urine- and blood samples, cardiac CT-scan (identifying coronary atherosclerotic changes) and questionnaires. These women will be compared to age-matched women, without previous preeclampsia investigated in the Copenhagen General Population Study with an identical CT protocol.
Tipo de estudio
Inscripción (Actual)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Copenhagen, Dinamarca, 2100
- Department of Cardiology and Radiology, Rigshospitalet, The Heart Center, Capital Region of Copenhagen, University of Copenhagen
-
Copenhagen, Dinamarca, 2100
- Department of Obstetrics, Rigshospitalet
-
Herlev, Dinamarca, 2730
- The Copenhagen General Population Study, Herlev-Gentofte Hospital, University of Copenhagen, Denmark
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
A total of 1000 women with previous preeclampsia will be invited to participate in a post-pregnancy clinical cardiovascular CT follow-up study. These women will be compared to age-matched women, without previous preeclampsia investigated in the Copenhagen General Population Study with an identical CT protocol.
Descripción
Inclusion Criteria
- Women with a history of preeclampsia
Exclusion Criteria
- Severe physical or mental disabilities
- Lack of ability to speak and/or understand Danish language
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: CASE_CONTROL
- Perspectivas temporales: PROSPECTIVE
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Coronary atherosclerosis
Periodo de tiempo: Assessed within 30 days of study inclusion
|
Presensence of coronary plaque as defined by Cardiac CT |
Assessed within 30 days of study inclusion
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Presence of left bundle branch block
Periodo de tiempo: Assessed within 30 days of study inclusion
|
Electrocardiographic abnormality |
Assessed within 30 days of study inclusion
|
|
Presence of atrial fibrillation
Periodo de tiempo: Assessed within 30 days of study inclusion
|
Electrocardiographic abnormality |
Assessed within 30 days of study inclusion
|
|
Presence of T-wave inversion
Periodo de tiempo: Assessed within 30 days of study inclusion
|
Electrocardiographic abnormality |
Assessed within 30 days of study inclusion
|
|
Presence of left ventricular hypertrophy
Periodo de tiempo: Assessed within 30 days of study inclusion
|
Electrocardiographic abnormality |
Assessed within 30 days of study inclusion
|
|
Arterial hypertension
Periodo de tiempo: Assessed within 30 days of study inclusion
|
Presence of elevated blood pressure |
Assessed within 30 days of study inclusion
|
|
Dyspnoe
Periodo de tiempo: Assessed within 30 days of study inclusion
|
New York Heart Association class |
Assessed within 30 days of study inclusion
|
|
Chest pain
Periodo de tiempo: Assessed within 30 days of study inclusion
|
Canadian Cardiovascular Society angina pectoris class |
Assessed within 30 days of study inclusion
|
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Major cardiovascular events
Periodo de tiempo: Assessed 1 year after Cardiac CT imaging
|
Composite endpoint of either death, myocardial infarction, heart failure or stroke |
Assessed 1 year after Cardiac CT imaging
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Silla de estudio: Peter Damm, MD, DmSc, Department of Obstetrics, Rigshospitalet, University of Copenhagen, Denmark
Publicaciones y enlaces útiles
Publicaciones Generales
- Hauge MG, Damm P, Kofoed KF, Ersboll AS, Johansen M, Sigvardsen PE, Moller MB, Fuchs A, Kuhl JT, Nordestgaard BG, Kober LV, Gustafsson F, Linde JJ. Early Coronary Atherosclerosis in Women With Previous Preeclampsia. J Am Coll Cardiol. 2022 Jun 14;79(23):2310-2321. doi: 10.1016/j.jacc.2022.03.381.
- Hauge MG, Damm P, Kofoed KF, Moller ELR, Lopez AG, Ersboll AS, Johansen M, Sigvardsen PE, Pham MHC, Goetze JP, Fuchs A, Kuhl JT, Nordestgaard BG, Kober LV, Gustafsson F, Linde JJ. Left Ventricular Hypertrophy in Women With a History of Preeclampsia. Hypertension. 2025 May;82(5):774-783. doi: 10.1161/HYPERTENSIONAHA.124.23497. Epub 2024 Nov 14.
- Hauge MG, Linde JJ, Kofoed KF, Ersboll AS, Johansen M, Sigvardsen PE, Fuchs A, Mikkelsen AP, Gustafsson F, Damm P. Early-onset vs late-onset preeclampsia and risk of coronary atherosclerosis later in life: a clinical follow-up study. Am J Obstet Gynecol MFM. 2024 May;6(5):101371. doi: 10.1016/j.ajogmf.2024.101371. Epub 2024 Apr 6.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Enfermedades urogenitales
- Enfermedades Vasculares
- Enfermedades urogenitales femeninas y complicaciones del embarazo
- Complicaciones del embarazo
- Infecciones
- Hipertensión, inducida por el embarazo
- Arteriosclerosis
- Enfermedades arteriales oclusivas
- Preeclampsia
- Enfermedades cardiovasculares
- Toxemia
- Aterosclerosis
Otros números de identificación del estudio
- H-18065695
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Logistics and patient data protection issues will be explored prior to decision on IPD
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .